Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
3.300
-0.060 (-1.79%)
Oct 19, 2026, 1:05 PM EDT - Market open
Scienture Holdings Revenue
Scienture Holdings had revenue of $343.64K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $821.32K, up 540.64% year-over-year. In the year 2025, Scienture Holdings had annual revenue of $431.61K with 215.87% growth. That makes Scienture Holdings the 43,908th largest company in the world by revenue and 6,174th in the United States.
Revenue (ttm)
$821.32K
Revenue Growth
+540.64%
P/S Ratio
6.72
Revenue / Employee
$91,257
Employees
9
Market Cap
5.42M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 431.61K | 294.97K | 215.87% |
| Dec 31, 2024 | 136.64K | -1.23M | -89.98% |
| Dec 31, 2023 | 1.36M | -8.89M | -86.69% |
| Dec 31, 2022 | 10.25M | 360.74K | 3.65% |
| Dec 31, 2021 | 9.89M | -7.23M | -42.24% |
| Dec 31, 2020 | 17.12M | 9.69M | 130.26% |
| Dec 31, 2019 | 7.44M | 3.60M | 94.07% |
| Dec 31, 2018 | 3.83M | 900.50K | 30.72% |
| Dec 31, 2017 | 2.93M | 449.41K | 18.11% |
| Dec 31, 2016 | 2.48M | -430.66K | -14.79% |
| Dec 31, 2015 | 2.91M | 1.42M | 94.66% |
| Dec 31, 2014 | 1.50M | 540.35K | 56.53% |
| Dec 31, 2013 | 955.88K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.06B |
| Johnson & Johnson | 99.34B |
| Eli Lilly and Company | 79.67B |
| AbbVie | 64.39B |
| Traws Pharma | 2.73M |
| Can-Fite BioPharma | 405.00K |
| Phaos Technology Holdings (Cayman) Limited | 103.68K |
SCNX News
- 3 days ago - DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap - Accesswire
- 5 days ago - DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform - Accesswire
- 6 days ago - Scienture reports preliminary Q3 revenue $1.22M, consensus $1.58M - TheFly
- 6 days ago - SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth - GlobeNewsWire
- 6 days ago - DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division - Accesswire
- 7 days ago - DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers - Accesswire
- 14 days ago - Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment - Accesswire
- 16 days ago - Scienture Holdings Inc trading halted, news pending - TheFly